Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation

Kidney International

Volumn 81, Issue 7, 2012, Pages 651-661

  Celie, Johanna W A M ^a,b   Katta, Kiran K ^c   Adepu, Saritha ^c   Melenhorst, Wynand B W H ^d   Reijmers, Rogier M ^b   Slot, Edith M ^a   Beelen, Robert H J ^a   Spaargaren, Marcel ^b   Ploeg, Rutger J ^c   Navis, Gerjan ^c   Van Der Heide, Jaap J Homan ^c   Van Dijk, Marcory C R F ^d   Van Goor, Harry ^d   Van Den Born, Jacob ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Department of Pathology ^*  (Netherlands)

Author keywords

kidney transplantation; proliferation; renal epithelial cell; renal ischemia reperfusion; transplant outcomes

Indexed keywords

CREATININE; FIBROBLAST GROWTH FACTOR 2; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MONOCLONAL ANTIBODY; SYNDECAN 1; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL COUNT; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MACROPHAGE FUNCTION; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; UPREGULATION; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BASE SEQUENCE; CELL LINE; EPITHELIAL CELLS; FEMALE; FIBROSIS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; REPERFUSION INJURY; RNA, SMALL INTERFERING; SYNDECAN-1; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84858330118     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.425     Document Type: Article

References (47)

1. Grinyo JM. Role of ischemia-reperfusion injury in the development of chronic renal allograft damage. Transplant Proc 2001; 33: 3741-3742.
2. Lien YH, Lai LW, Silva AL. Pathogenesis of renal ischemia/reperfusion injury: Lessons from knockout mice. Life Sci 2003; 74: 543-552.
3. Hoffmann SC, Kampen RL, Amur S et al. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002; 74: 916-923.
4. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 2006; 81: 643-654.
5. Bunnag S, Einecke G, Reeve J et al. Molecular correlates of renal function in kidney transplant biopsies. J Am Soc Nephrol 2009; 20: 1149-1160.
6. Celie JW, Rutjes N, Keuning ED et al. Subendothelial heparan sulfate proteoglycans become major L-selectin and MCP-1 ligands upon renal ischemia/reperfusion. Am J Pathol 2007; 170: 1865-1878.
7. Celie JW, Reijmers RM, Slot EM et al. Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria. Am J Physiol Renal Physiol 2008; 294: F253-F263.
8. Esko JD, Selleck SB. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71: 435-471.
9. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Science 2000; 113: 193-205.
10. Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 2007; 39: 505-528.
11. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol 2006; 6: 633-643.
12. Whitelock JM, Iozzo RV. Heparan sulfate: A complex polymer charged with biological activity. Chem Rev 2005; 105: 2745-2764.
13. Wang L, Fuster M, Sriramarao P et al. Endothelial heparan sulfate deficiency impairs L-selectin-and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 2005; 6: 902-910.
14. Kreuger J, Spillmann D, Li JP et al. Interactions between heparan sulfate and proteins: The concept of specificity. J Cell Biol 2006; 174: 323-327.
15. Elenius K, Vainio S, Laato M et al. Induced expression of syndecan in healing wounds. J Cell Biol 1991; 114: 585-595.
16. Stepp MA, Gibson HE, Gala PH et al. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J Cell Sci 2002; 115: 4517-4531.
17. Kato M, Saunders S, Nguyen H et al. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchymelike cells. Mol Biol Cell 1995; 6: 559-576.
18. Vainio S, Lehtonen E, Jalkanen M et al. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 1989; 134: 382-391.
19. Venkatachalam MA, Griffin KA, Lan R et al. Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F1078-F1094.
20. Guerrini M, Hricovini M, Torri G. Interaction of heparins with fibroblast growth factors: Conformational aspects. Curr Pharm Des 2007; 13: 2045-2056.
21. Chu CL, Goerges AL, Nugent MA. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry 2005; 44: 12203-12213.
22. Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997; 1333: F179-F199.
23. Clayton A, Thomas J, Thomas GJ et al. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2. Kidney Int 2001; 59: 2084-2094.
24. Zhuang S, Kinsey GR, Rasbach K et al. Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells. Am J Physiol Renal Physiol 2008; 294: F459-F468.
25. Sakai M, Zhang M, Homma T et al. Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules. J Clin Invest 1997; 99: 2128-2138.
26. Alexander CM, Reichsman F, Hinkes MT et al. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 2000; 25: 329-332.
27. Watanabe A, Mabuchi T, Satoh E et al. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: Participation of nuclear factor-kappaB in upregulation of syndecan-1 expression. J Neurooncol 2006; 77: 25-32.
28. Jaakkola P, Jalkanen M. Transcriptional regulation of Syndecan-1 expression by growth factors. Prog Nucleic Acid Res Mol Biol 1999; 63: 109-138.
29. Jaakkola P, Vihinen T, Jalkanen M. Proximal promoter-independent activation of the far-upstream FGF-inducible response element of syndecan-1 gene. Biochem Biophys Res Commun 2000; 278: 432-439.
30. Loverre A, Ditonno P, Crovace A et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: Differential modulation by rapamycin. J Am Soc Nephrol 2004; 15: 2675-2686.
31. Villanueva S, Cespedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 2006; 290: R861-R870.
32. Hayashida K, Johnston DR, Goldberger O et al. Syndecan-1 expression in epithelial cells is induced by transforming growth factor beta through a PKA-dependent pathway. J Biol Chem 2006; 281: 24365-24374.
33. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217.
34. Stein-Oakley AN, Tzanidis A, Fuller PJ et al. Expression and distribution of epidermal growth factor in acute and chronic renal allograft rejection. Kidney Int 1994; 46: 1207-1215.
35. van Timmeren MM, Vaidya VS, van Ree RM et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007; 84: 1625-1630.
36. Malyszko J, Koc-Zorawska E, Malyszko JS et al. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients. Transplant Proc 2010; 42: 3957-3959.
37. Nauta FL, Bakker SJ, van Oeveren W et al. Albuminuria, proteinuria, and novel urine biomarkers of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis 2011; 57: 733-743.
38. Vongwiwatana A, Tasanarong A, Rayner DC et al. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis. Am J Transplant 2005; 5: 1367-1374.
39. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
40. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: New diagnostic insights and standards. Am J Transplant 2004; 4: 1562-1566.
41. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526.
42. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760.
43. van den Born J, Gunnarsson K, Bakker MA et al. Presence of Nunsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 1995; 270: 31303-31309.
44. van den Born J, van den Heuvel LP, Bakker MA et al. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. Lab Invest 1991; 65: 287-297.
45. David G, Bai XM, Van der Schueren B, Cassiman JJ et al. Developmental changes in heparan sulfate expression: In situ detection with mAbs. J Cell Biol 1992; 119: 961-975.
46. Snow AD, Mar H, Nochlin D et al. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 1990; 137: 1253-1270.
47. Ryan MJ, Johnson G, Kirk J et al. HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48-57.